Study Information
Status: Active, Not Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
East Bay
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
Principal Investigator
Related Studies
COVID-19 Universal Registry for Vital Evaluations (CURVE) Project
To create a COVID-19 Universal Registry for Vital Evaluations (CURVE) database, a
semi-real-time registry of Sutter Health patients with COVID-19 infection.
Investigator: Jiang Li, Ph.D., MPH
Impact of COVID-19 on Cancer Care Management
Study will enhance understanding of cancer care management due to COVID-19.
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Maternal CARE Study
By testing pregnant women's blood samples for COVID-19 antibodies, study team will
examine spread of the virus in pregnancy and variations in infection rates.
Investigators: Gregory J. Tranah, Ph.D., Alice R. Pressman, Ph.D., M.S.
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Using EHR from a large healthcare system in Northern CA, we will study the impact
of smoking, comorbidities, race on COVID-19 infection and disease severity.
Investigator: Jiang Li, Ph.D., MPH